Form 4: Amylyx Pharmaceuticals Chief Legal Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Gina Mazzariello, Chief Legal Officer of Amylyx Pharmaceuticals, sold 1,611 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 3, 2025, Gina Mazzariello, the Chief Legal Officer of Amylyx Pharmaceuticals, sold 1,611 shares of common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted average price of $3.1175, with individual transactions ranging from $3.10 to $3.165.
- Following the transaction, Mazzariello directly owns 133,310 shares of Amylyx Pharmaceuticals.
- The sale was automatic and not at the discretion of the reporting person.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and does not contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally viewed as routine transactions.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of the transaction (sale of shares). |
| 03/05/2025 | Date of signature of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.